
About Pfizer Healthcare India Private Limited
Data last updated:
Pfizer Healthcare India Private Limited is a private limited company based in Chennai, Tamil Nadu, India, a subsidiary of Hospira Pte Ltd. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2009PTC073563. Its GSTIN is 33AABCO2190F1ZT (Tamil Nadu). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹6.93 Cr. It was formerly known as Ojas Pharmaceuticals India Private Limited and Hospira Healthcare India Private Limited. It is led by directors including Andrew Gordon Mc Killop and Kannan Natarajan.
Its last annual general meeting (AGM) was held on 07 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Emerald Building No. 237 Anna Salai, Chennai, Tamil Nadu, India – 600006.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,981.45 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹181.8 Cr (net margin 9.2%) and EBITDA of ₹494.01 Cr (EBITDA margin 24.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 6% over five years.
The company has about 3,532 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pfizer. Court records list 67 cases involving the company, including 42 filed by the company and 25 filed against it; 14 cases are pending. The company has 6 deals on record (2 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹2,843.05 Cr; the latest was in March 2020. The company has 22 MSME Form 1 returns on record between 2016 and 2024, listing 1,869 overdue payments to 310 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pfizer.com.
Company details
Name history
Pfizer Healthcare India has undergone 2 name changes throughout its history. The company was previously known as Ojas Pharmaceuticals India Private Limited, and Hospira Healthcare India Private Limited. The current legal name is Pfizer Healthcare India Private Limited.
| Company Name | Status |
|---|---|
| Pfizer Healthcare India Private Limited | Current |
| Ojas Pharmaceuticals India Private Limited | Previous |
| Hospira Healthcare India Private Limited | Previous |
CIN history
Pfizer Healthcare India has one previous CIN (Corporate Identification Number): U21002TN2009PTC073563. The current CIN is U24232TN2009PTC073563, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TN2009PTC073563 | Current |
| U21002TN2009PTC073563 | Previous |
Contact details
Pfizer Healthcare India Private Limited's registered office is in Chennai, Tamil Nadu. Its website is pfizer.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressEmerald Building No. 237 Anna Salai, Chennai, Tamil Nadu, India – 600006
- IndustryPharma, API Manufacturers
To see the full contact details of Pfizer Healthcare India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Pfizer Healthcare India operates one associated brand: Pfizer. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products for treating multiple diseases are provided. | pfizer.com |
Business activity
The main business activities of Pfizer Healthcare India are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Pfizer Healthcare India Private Limited, buy the company report.
Financials of Pfizer Healthcare India Private Limited
FY 2025 filings availablePfizer Healthcare India Private Limited reported revenue of ₹1,981.45 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 4% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,981.45 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹494.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹181.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.9% | ||||
| Net Profit Margin | 9.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pfizer Healthcare India Private Limited, buy the company report.
Board of directors and KMP of Pfizer Healthcare India Private Limited
Pfizer Healthcare India Private Limited currently reports 6 directors and 1 key managerial person. 31 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Andrew Gordon Mc Killop | Director | 25 Jan 2024 | 2 Years 9 Months | Current |
| Jayaraman Aparajith | Company Secretary | 28 Jul 2022 | 4 Years 3 Months | Current |
| Kannan Natarajan | Director | 13 Mar 2019 | 7 Years 8 Months | Current |
| Fiona Kathleen Maccarthy | Director | 20 Feb 2023 | 3 Years 9 Months | Current |
| Andrew David Chatfield Also directs: Zydus Hospira Oncology Private Limited | Director | 20 Dec 2018 | 7 Years 11 Months | Current |
| Muralidhar B Sharma | Director | 19 Dec 2024 | 1 Years 11 Months | Current |
Auditor
Pfizer Healthcare India Private Limited is audited by B S R & Co. LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2025 | 101248W/W-100022 |
Shareholding
The shareholding of Pfizer Healthcare India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Pfizer Healthcare India Private Limited, buy the company report.
Deals & funding
Pfizer Healthcare India Private Limited has 6 deals on record (2 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹2,843.05 Cr; the latest was in March 2020.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2020 | Rights issue | ₹1,154.87 Cr | Investors: Hospira Pte. Limited |
| Jul 2014 | Rights issue | ₹1,134.6 Cr | Investors: Hospira Pte. Limited |
| Dec 2012 | Funding round | ₹1,613.05 Cr | Investors: Hospira Pte. Limited |
| Mar 2010 | Funding round | ₹1,230 Cr | Investors: Hospira Pte. Limited |
| Dec 2009 | Secondary share transfer | Undisclosed | Buyer: Hospira Pte. Limited Seller: an individual |
To see the full deal history of Pfizer Healthcare India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Pfizer Healthcare India Private Limited has 67 court cases on record: 42 filed by Pfizer Healthcare India, 25 filed against it. 14 cases are pending and 53 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 53 | 14 | 10 |
| District courts | 9 | 7 | 1 |
| Supreme Court | 4 | 4 | 3 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 67)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, Kancheepuram, Tamil Nadu | Civil suit | Filed by the company against Viswanetra Agencies Private Ltd., Rep. by Managing Director | Disposed |
| Madras High Court | Interim or miscellaneous application | Filed by the company against The Deputy Commissioner of Income Tax, | Pending |
| Supreme Court | Interim or miscellaneous application | Filed against the company by Joint Commissioner of Income Tax | Pending |
| District court, Hyderabad CCC, Telangana | Court case (MVOP) | Filed against the company | Pending |
To see the full case history of Pfizer Healthcare India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Pfizer Healthcare India Private Limited has 22 MSME Form 1 returns on record between 2016 and 2024, listing 1,869 overdue payments to 310 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 310)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| C N Tech Engineers Private Limited | |||
| an individual supplier | |||
| Festex India Private Limited | |||
| Conquer Technologies |
To see the full MSME payment records of Pfizer Healthcare India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Pfizer Healthcare India Private Limited has a workforce of 3,532 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 3,532 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 | |
| FY 2013-14 | |
| FY 2012-13 |
To see the full employee and EPFO history of Pfizer Healthcare India Private Limited, buy the company report.
GST
Pfizer Healthcare India has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AABCO2190F1ZT | Tamil Nadu | Active | 01 Jul 2017 |
| 27AABCO2190F1ZM | Maharashtra | Active | 01 Jul 2017 |
| 37AABCO2190F1ZL | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Pfizer Healthcare India Private Limited, buy the company report.
Recent activity
Pfizer Healthcare India Private Limited has 36 board changes on record since 2010: 7 appointments and 29 cessations. The latest: Muralidhar B Sharma ceased to be Additional Director on 06 Aug 2025.
27 earlier events are in the company report.
News
Frequently asked questions
Pfizer Healthcare India is an active private limited company based in Chennai, Tamil Nadu, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 17 November 2009 (17+ years old) and is registered under CIN U24232TN2009PTC073563.
Pfizer Healthcare India has 7 current directors and KMP:
- Andrew Gordon Mc Killop - Director
- Kannan Natarajan - Director
- Fiona Kathleen Maccarthy - Director
- Andrew David Chatfield - Director
- Muralidhar B Sharma - Director
- Wriju Ghosh - Director
- Jayaraman Aparajith - Company Secretary
The latest financial statements of Pfizer Healthcare India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 07 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Pfizer Healthcare India is 33AABCO2190F1ZT, registered in Tamil Nadu. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 27AABCO2190F1ZM (Maharashtra), 37AABCO2190F1ZL (Andhra Pradesh).
The CIN (Corporate Identification Number) of Pfizer Healthcare India is U24232TN2009PTC073563. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pfizer Healthcare India has 67 court cases on record: 42 filed by the company and 25 filed against it. 14 are pending. Most are in the high courts.
Pfizer Healthcare India was incorporated on 17 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Chennai.
Pfizer Healthcare India has 6 deals on record (2 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹2,843.05 Cr; the latest was in March 2020.
Muralidhar B Sharma ceased to be Additional Director on 06 Aug 2025. Muralidhar B Sharma was appointed as Director on 19 Dec 2024. Andrew Gordon Mc Killop ceased to be Additional Director on 08 Aug 2024. Pfizer Healthcare India has 36 board changes on record in total.
Pfizer Healthcare India has 22 MSME Form 1 returns on record between 2016 and 2024, listing 1,869 overdue payments to 310 micro and small suppliers. The latest return was filed on 26 Apr 2024.
Pfizer Healthcare India can be reached through the website pfizer.com. Its registered office is in Chennai, Tamil Nadu, India.

